IndiaOne Finance - Company Dashboard

Governance Classic Home

SMS Pharmaceuticals LtdPharmaceuticalsINE812G01025Consolidated₹466.50+23.55 (+5.32%)Jun-26

Valuation

Market Cap₹4.37K Cr

TTM PE41.50x

Forward PE41.65x

PEG-58.45

Book Value₹83.91

P/B5.56x

TTM EPS₹11.24

Fwd EPS₹11.20

TTM Revenue₹897.79 Cr

TTM PAT₹102.40 Cr

TTM EBITDA₹172.87 Cr

TTM EBIT₹132.71 Cr

Last Qtr PAT₹20.91 Cr

Last Qtr EBITDA₹40.95 Cr

Last Qtr EBIT₹30.96 Cr

Profitability

ROE13.03%

ROCE12.36%

TTM NPM11.41%

TTM EBITDA %19.26%

Curr OPM10.02%

Last OPM13.60%

Curr NPM—

Last NPM—

Curr EPS₹2.23

Last EPS₹3.58

Balance sheet

Equity₹9.37 Cr

Reserve₹776.44 Cr

Total Debt₹365.05 Cr

D/E0.46x

Interest %26.30%

Curr Interest₹5.50 Cr

Price / range

Close₹466.50

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+5.32%

1W+0.66%

1M+30.82%

3M+23.22%

6M+21.26%

1Y+59.49%

2Y+26.54%

3Y+283.95%

5Y+204.50%

Diwali+48.99%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1868.90	₹4.48L Cr	37.08	14.50%
DIVISLAB	9410.50	₹2.50L Cr	85.39	17.45%
TORNTPHARM	4970.00	₹1.89L Cr	79.39	25.70%
ZYDUSLIFE	1161.00	₹1.16L Cr	25.87	16.94%
CIPLA	1386.10	₹1.12L Cr	33.21	9.75%
LAURUSLABS	2017.50	₹1.09L Cr	99.58	20.58%
MANKIND	2437.80	₹1.01L Cr	49.26	12.68%
DRREDDY	1198.30	₹1.00L Cr	30.97	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	206.96+5.6%	237.95	210.45	242.43	196.05	886.87
Other Income	1.74	2.57	3.75	1.43	0.59	8.35
Total Income	208.71+6.1%	240.52	214.20	243.86	196.64	895.22
Interest	5.50	5.28	6.22	5.74	5.84	23.08
Expenditure	-180.57-4.5%	-213.48	-182.89	-209.81	-172.78	-778.95
PBDT	0	0	0	0	0	0
EBITDA	41.88+7.8%	39.88	43.80	48.38	38.86	170.92
Depreciation	-9.99	-10.13	-10.02	-10.02	-9.75	-39.92
EBIT	31.89+9.5%	29.75	33.78	38.36	29.11	131
PBT	28.14+17.9%	27.05	31.31	34.06	23.86	116.27
Tax	-7.01	-6.12	-7.97	-8.91	-5.65	-28.66
Equity	9.37	9.37	0	0	8.87	9.37
OPM	13.48	11.25	14.88	14.05	12.13	12.99
Net Profit	21.13+16.0%	20.92	23.34	25.14	18.21	87.61
NPM	10.12	8.70	11.09	10.37	9.26	9.79
EPS	2.26+10.2%	2.29	2.57	2.82	2.05	9.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	886.87+13.3%	782.75+10.4%	709.26+35.9%	522.05+0.4%	519.87-7.7%	563.18
Other Income	8.35	6.22	4.46	4.89	5.20	3.45
Total Income	895.22+13.5%	788.97+10.5%	713.72+35.4%	526.94+0.4%	525.07-7.3%	566.63
Expenditure	-778.95-12.0%	-695.65-7.5%	-647.39-24.2%	-521.39-14.2%	-456.42+4.0%	-475.51
Interest	-23.08	-18.54	-23.46	-21.92	-18.88	-11.16
PBDT	0	0	0	0	0	0
EBITDA	170.92+22.1%	139.98+19.8%	116.85+113.6%	54.71-52.2%	114.48-5.5%	121.11
Depreciation	-39.92	-34.34	-31.52	-32.13	-32.15	-22.28
EBIT	131+24.0%	105.64+23.8%	85.33+277.9%	22.58-72.6%	82.33-16.7%	98.83
PBT	116.27+24.6%	93.32+40.7%	66.33+1095.1%	5.55-91.9%	68.66-24.6%	91.12
Tax	-28.66	-24.94	-16.91	-1.47	-0.62	-30.16
Equity	9.37	8.87	0	0	0	0
OPM (%)	12.99	11.83	9.00	1.00	13.00	16.00
Net Profit	87.61+28.1%	68.38+38.3%	49.43+1108.6%	4.09-94.0%	68.04+11.6%	60.97
NPM (%)	9.79	8.67	7.00	1.00	13.00	11.00
EPS (Rs)	9.58+18.7%	8.07+38.2%	5.84+1116.7%	0.48-94.0%	8.04+11.7%	7.20
CEPS	9.58	8.07	5.84	0.48	8.04	7.20

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	206.96+5.6%	237.95	210.45	242.43	196.05	886.87
Other Income	1.74	2.57	3.75	1.43	0.59	8.35
Total Income	208.71+6.1%	240.52	214.20	243.86	196.64	895.22
Interest	5.50	5.28	6.22	5.74	5.84	23.08
Expenditure	-181.50-5.4%	-213.46	-183.04	-209.82	-172.27	-778.59
PBDT	0	0	0	0	0	0
EBITDA	40.95+4.0%	39.90	43.65	48.37	39.37	171.28
Depreciation	-9.99	-10.13	-10.02	-10.02	-9.75	-39.92
EBIT	30.96+4.5%	29.77	33.63	38.35	29.62	131.36
PBT	27.21+11.7%	27.07	31.16	34.04	24.37	116.64
Tax	-7	-6.10	-7.97	-8.91	-5.65	-28.64
Equity	9.37	9.37	0	0	8.87	9.37
OPM	13.04	11.25	14.55	13.96	12.39	13.03
Net Profit	20.91+2.0%	32.71	23.47	25.31	20.49	101.99
NPM	10.02	13.60	10.96	10.38	10.42	11.39
EPS	2.23-3.5%	3.58	2.59	2.84	2.31	11.15

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	886.87+13.3%	782.75+10.4%	709.26+35.9%	522.05+0.4%	519.87-7.7%	563.18
Other Income	8.35	6.22	4.46	4.89	5.20	3.45
Total Income	895.22+13.5%	788.97+10.5%	713.72+35.4%	526.94+0.4%	525.07-7.3%	566.63
Expenditure	-778.59-11.8%	-696.64-7.6%	-647.62-24.2%	-521.59-14.2%	-456.57+4.0%	-475.51
Interest	-23.08	-18.54	-23.46	-21.92	-18.88	-11.16
PBDT	0	0	0	0	0	0
EBITDA	171.28+23.2%	138.99+19.2%	116.62+113.9%	54.51-52.3%	114.33-5.6%	121.11
Depreciation	-39.92	-34.34	-31.52	-32.13	-32.15	-22.28
EBIT	131.36+25.5%	104.65+23.0%	85.10+280.3%	22.38-72.8%	82.18-16.8%	98.83
PBT	116.64+26.3%	92.34+39.7%	66.11+1135.7%	5.35-92.2%	68.50-24.8%	91.12
Tax	-28.64	-24.94	-16.91	-1.47	-0.62	-30.16
Equity	9.37	8.87	0	0	0	0
OPM (%)	13.03	11.70	9.26	1.02	13.05	16.08
Net Profit	101.99+47.5%	69.14+38.8%	49.83+805.8%	-7.06-111.3%	62.22-0.5%	62.53
NPM (%)	11.39	8.76	6.98	-1.34	11.85	11.03
EPS (Rs)	11.15+36.6%	8.16+38.5%	5.89+809.6%	-0.83-111.3%	7.35-0.5%	7.39
CEPS	11.15	8.16	5.89	0	7.35	7.39

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.4	16 Sep 2026
2025	Final Dividend	0.4	22 Sep 2025
2024	Final Dividend	0.4	23 Sep 2024
2023	Final Dividend	0.3	22 Sep 2023
2022	Final Dividend	0.3	22 Sep 2022
2021	Final Dividend	0.3	22 Sep 2021
2020	Interim Dividend	0.25	26 Mar 2020
2019	Final Dividend	0.25	19 Sep 2019
2018	Final Dividend	0.25	11 Sep 2018
2017	Final Dividend	0.2	20 Sep 2017
2016	Final Dividend	0.2	22 Sep 2016
2015	Final Dividend	2	22 Sep 2015
2014	Final Dividend	2	23 Sep 2014
2013	Final Dividend	2	23 Sep 2013
2011	Final Dividend	1.5	22 Sep 2011
2010	Final Dividend	1	23 Sep 2010
2009	Final Dividend	2	23 Sep 2009
2008	Final Dividend	2	23 Dec 2008

Bonus

No bonus history.

Split

Year	Ratio	Ex-Date
2015	Rs.10/- to Rs.1/-	17 Dec 2015

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split